Telix shares jump 7.2% after new partnership revealed
MELBOURNE: Shares in cancer pharmaceuticals developer Telix jumped as much as 7.2 per cent to
MELBOURNE: Shares in cancer pharmaceuticals developer Telix jumped as much as 7.2 per cent to